Analyst firms · Goldman Sachs · TSVT

Goldman Sachs TSVT price target and rating history

2seventy bio Inc. (TSVT) · Health Care

Goldman Sachs rates 2seventy bio Inc. (TSVT) Sell with a $2 price target, as of its latest action on Jun 6, 2024. It has published 3 rating actions on TSVT since May 2022, including 0 upgrades and 2 downgrades.

Current rating
Sell
Price target
$2
Median target, all firms
Too few
Actions on TSVT
3

Goldman Sachs price target on TSVT

$26$14$22023202420252026
Goldman Sachs price target on TSVT, each point a stated target, May 2022 to June 2024.

Every Goldman Sachs rating on TSVT

Questions about Goldman Sachs and TSVT

What is Goldman Sachs's price target for TSVT?
Goldman Sachs's latest stated price target for 2seventy bio Inc. (TSVT) is $2, from its action on Jun 6, 2024.
What is Goldman Sachs's rating on TSVT?
Goldman Sachs rates TSVT Sell, a bearish rating, as of Jun 6, 2024.
When did Goldman Sachs last change its view on TSVT?
On Jun 6, 2024, Goldman Sachs downgrades to Sell from Neutral, price target $5 to $2.

More TSVT rating histories

All Goldman Sachs ratingsTSVT news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.